HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PI 2301

a 52-mer random peptide consisting of tyrosine, alanine, lysine, and phenylalanine; has immunomodulatory activity

Also Known As:

PI-2301; PI2301

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - PI 2301: 2

Experts

1.	Augustyniak, Michael: 1 article (05/2011)
2.	Avril, Tony: 1 article (05/2011)
3.	Collins, Kathy: 1 article (05/2011)
4.	Fauchoux, Nicolas: 1 article (05/2011)
5.	Gandon, Gwenola: 1 article (05/2011)
6.	Genova, Michelle: 1 article (05/2011)
7.	Kovalchin, Joseph: 1 article (05/2011)
8.	Krieger, Jeffrey: 1 article (05/2011)
9.	Lacoste, Eric: 1 article (05/2011)
10.	Masci, Allyson: 1 article (05/2011)

Related Diseases

1.	Chronic Progressive Multiple Sclerosis 08/25/2010 - "Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response."
2.	Autoimmune Diseases (Autoimmune Disease) 05/01/2011 - "PI-2301 is an amino acid copolymer acting as an immunomodulator for the treatment of autoimmune diseases. "
3.	Injection Site Reaction 05/01/2011 - "A total of 56 subjects were given a subcutaneous injection of PI-2301 ranging from 0.035 to 60 mg. The only consistent side effect was transient injection site reactions. "

Related Drugs and Biologics

1.	Amino Acids
2.	Cytokines
3.	Immunologic Factors (Immunomodulators)

Related Therapies and Procedures

1.	Subcutaneous Injections